Zeagoo Women's Jackets Win Silver at the 2025 Berlin Design Awards
The issuer is solely responsible for the content of this announcement.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Star
5 hours ago
- The Star
Taiwan investors turn to Europe over US assets
Over the first half of 2025, Taiwanese investors have also poured 14.1 billion New Taiwan dollars into Europe-focused funds based overseas. — Bloomberg TAIPEI: Taiwanese investors are reassessing their long-held preference for US-dollar assets, shifting their bets to Europe in the latest move by global investors away from the greenback. Taiwanese funds holding European assets have seen an influx of investments recently, pushing their combined value to 13.7 billion New Taiwan dollars (US$463mil) as of the end of June, the highest since 2019, according to data compiled by Bloomberg. Over the first half of 2025, Taiwanese investors have also poured 14.1 billion New Taiwan dollars into Europe-focused funds based overseas, according to data from the Securities Investment Trust and Consulting Association (Sitca). At the same time, Taiwan-based funds focusing on the United States saw their combined value fall by 538 billion New Taiwan dollars over the first half of 2025, the largest six-month decline since Bloomberg started compiling the data in 2003. Taiwanese assets in US-focused overseas funds declined by 121.6 billion New Taiwan dollars, the biggest contraction since Sitca records began in 2006. — Bloomberg Trading ideas: FGV, Paramount ,Zetrix, United Malacaa, Jati Tinggit, Focus Point, Camaroe, Bursa, IGBREIT, Chin Teck, Dufu, DXN, Tasco
Malay Mail
a day ago
- Malay Mail
AstraZeneca beats Q2 forecasts on booming US drug sales, eyes US$80b revenue by 2030
LONDON, July 29 — AstraZeneca Tuesday beat second-quarter revenue and profit expectations on robust sales of newer cancer, heart and kidney disease medicines and strong demand in the US, where it has invested US$50 billion (RM212 billion) to expand amid tariff threats from Washington. The performance is a boost for the UK's largest-listed company by market value as the wider sector braces for US tariffs on pharmaceutical imports and navigates pressure after President Donald Trump's order pushing for drugmakers to cut US prices to what other countries pay. AstraZeneca shares rose as much as 2.2 per cent by 0813 GMT. The drugmaker in April forecast only a limited impact from potential US tariffs, adding it would be able to meet its annual outlook if the levies on European imports were similar to those in other industries. A European Union-US trade deal over the weekend will result in a 15 per cent tariff on pharmaceuticals from the region. The US accounted for more than 40 per cent of AstraZeneca's revenue in 2024. The company had prioritised the market — the world's largest, worth US$635 billion — even before Trump's return to office. AstraZeneca is betting on a wave of expected launches of 20 new medicines and its US expansion to reach US$80 billion in annual revenue by 2030 and offset generic competition. On Tuesday, it maintained its 2025 outlook and increased its interim dividend by 3 per cent. 'Our strong momentum in revenue growth continued through the first half of the year and the delivery from our broad and diverse pipeline has been excellent,' CEO Pascal Soriot said. Cancer drugs outperform Sales of oncology drugs, constituting nearly half of AstraZeneca's revenue, were up 18 per cent at US$6.31 billion at constant currency rates in the quarter. Jefferies analysts said sales of drugs including Tagrisso, Lynparza, Calquence, Truqap and Imfinzi beat expectations. Total revenue for the three months ended June grew 11 per cent to US$14.46 billion, with double-digit growth in the US despite headwinds from changes in US Medicare price negotiations. Core earnings stood at US$2.17 per share. That compares with analysts' expectations of US$2.16, and US$14.15 billion in sales, according to a company-provided consensus. 'Operationally, this is the type of quarter we want to see,' Barclays analysts said. AstraZeneca is also hoping to move on from scandals in its second-biggest market, China, where it this year faced minor fines related to cancer drugs. It is also fighting patent challenges from an individual against Tagrisso. The company also delayed late-stage Avanzar trial data for a key lung cancer treatment to the first half of 2026. — Reuters
Malay Mail
a day ago
- Malay Mail
Skyborn enters Preferred Supplier Agreement with Fred. Olsen Windcarrier for Gennaker offshore installation vessel
Gennaker's offshore wind turbine transportation and installation will be performed by Fred. Olsen Windcarrier (Fred Olsen). Installation of 63 offshore wind turbines during 2028 in the German Baltic Sea. Gennaker will add up to 976.5 MW to Germany's renewables capacity*. Fred. Olsen Windcarrier's installation vessel - Brave Tern ©Fred. Olsen Windcarrier HAMBURG, GERMANY - EQS Newswire - 29 July 2025 - Skyborn Renewables (Skyborn) is proud to announce an entry into the Preferred Supply Agreement (PSA) with Fred. Olsen Windcarrier for the offshore transportation and installation of the wind turbines generators for the Gennaker offshore wind farm in the Baltic Sea. The Charter Party Agreement is expected to be signed later in installation at sea of the 63 turbines is set to begin in 2028 and will be performed by Fred Olsen Windcarrier's installation vessel - Brave Tern. The selected self-elevating and self-propelled jack-up offshore wind turbine installation vessel is designed and built to align with Skyborn's commitment to excellence in safety and operations. The vessel can handle all next-generation turbines due to its unique 1,600 tonnes PSA signed on 24 July 2025 solidifies the longstanding, trusted partnership between Skyborn and Fred. Olsen Windcarrier."After last weeks' successful agreements for the wind turbines supply and their long-term service , this newly formed arrangement with Fred. Olsen Windcarrier is another step towards Gennaker becoming a reality. With Fred. Olsen Windcarrier's long lasting experience in offshore wind, Gennaker will benefit from state-of-the-art offshore installation capacity. Gennaker, our blue-print project, is the showcase of our end-to-end delivery capabilities, with standardized process to bring new offshore wind projects to life every 12 to 18 months." says Patrick Lammers, Skyborn CEO."We are extremely proud to enter the Preferred Supply Agreement (PSA) with Skyborn for the offshore transportation and installation of the wind turbines generators for the Gennaker offshore wind farm. This agreement demonstrates our long-term commitment to offshore wind and underlines the strong and trustful relationship between the companies. With our strong experience from the Baltic Sea region, we look forward to the execution of the Gennaker project together with Skyborn and all the local stakeholders and suppliers on the project" says Haakon Magne CEO at Fred. Olsen a capacity up to 976.5 MW, Gennaker is to become the largest offshore wind farm in the German Baltic Sea to date. Located approximately 15 kilometers north of the Fischland-Darß-Zingst peninsula, the project area sits within a designated priority zone for offshore wind energy in the Mecklenburg-Western Pomerania coastal sea. Skyborn secured the initial building permit for the Gennaker site in May 2019 and maintains site exclusivity for development. Once commissioned, the project will supply approximately 1 million people with green electricity. Gennaker is planned to be commissioned in press release and picture are available at: Hashtag: #Skyborn The issuer is solely responsible for the content of this announcement. About Skyborn Renewables Skyborn is an accomplished offshore wind developer and operator with more than 20 years' experience, headquartered in Germany. The company's capabilities cover the entire offshore wind value chain, including greenfield development, project engineering and design, procurement, financing, corporate power purchase agreements, construction management and asset management. Skyborn is a portfolio company of New York based Global Infrastructure Partners (GIP), a leading infrastructure investor and part of Blackrock. For more information, visit: Follow us on LinkedIn: About Fred. Olsen Windcarrier Fred. Olsen Windcarrier offers innovative and tailored services for the transport, installation, and maintenance of offshore wind farms. The company was established in 2008 to service the growing offshore wind sector and has installed more than 1100 wind turbines offshore – which is more than 20% of all offshore wind turbines worldwide outside China. Fred. Olsen Windcarrier operates the three self-elevating jack-up vessels – Bold Tern, Brave Tern and Blue Tern. For more information, visit: Follow us on LinkedIn:
